What is the appropriate work‑up, including specific laboratory tests, for evaluating suspected paraproteinemia?

Workup for Suspected Paraproteinemia

The initial laboratory workup for suspected paraproteinemia must include serum protein electrophoresis (SPEP) with immunofixation, quantitative immunoglobulins by nephelometry, 24-hour urine collection for protein electrophoresis (UPEP) with immunofixation, serum free light chain assay, complete blood count, comprehensive metabolic panel (including calcium, creatinine, and albumin), serum β2-microglobulin, and lactate dehydrogenase 1.

Core Laboratory Testing Algorithm

Initial Screening Tests (All Patients)

Serum Studies:

• SPEP using agarose gel or capillary zone electrophoresis - screens for monoclonal protein presence 1
• Serum immunofixation - confirms and types the monoclonal protein (heavy and light chain) 1
• Quantitative immunoglobulins by nephelometry - measures IgG, IgA, IgM levels; particularly useful for low-level paraproteins and IgA/IgD myeloma 1
• Serum free light chain assay - essential for detecting light chain-only disease and nonsecretory/oligosecretory cases 1

Important caveat: Both SPEP densitometry and nephelometric quantitation are complementary and should be performed together, as nephelometry may overestimate monoclonal protein at high concentrations 1.

Urine Studies:

• 24-hour urine collection for total protein, UPEP, and urine immunofixation - cannot be replaced by random urine samples 1
• Immunofixation should be performed even if no measurable protein or peak is visible on electrophoresis 1

Blood and Chemistry Panel

• Complete blood count with differential - evaluate for anemia, rouleaux formation, circulating plasma cells 1
• Comprehensive metabolic panel including:
  • Serum creatinine (renal function)
  • Corrected calcium (hypercalcemia assessment)
  • Albumin (prognostic value)
  • Liver function tests 1

Prognostic Markers

• Serum β2-microglobulin - reflects tumor burden and forms basis of International Staging System 1
• Serum lactate dehydrogenase (LDH) - independent prognostic significance 1

Note: Erythrocyte sedimentation rate provides no additional information and is not required 1.

Bone Marrow Evaluation

Unilateral bone marrow aspirate and/or biopsy is required when paraproteinemia is confirmed 1:

• Diagnosis confirmed with ≥10% clonal plasma cells
• CD138 staining should be used to accurately determine plasma cell percentage 1
• Cytogenetic studies are mandatory:
  • Metaphase karyotype
  • FISH analysis for high-risk features: chromosome 17p13 deletion, t(4;14), t(14;16) 1
  • FISH preferably performed after plasma cell sorting 1

Imaging Studies

Skeletal survey remains the standard initial imaging 1:

• Posteroanterior chest view
• Anteroposterior and lateral views: cervical/thoracic/lumbar spine, humeri, femora, skull
• Anteroposterior pelvis view

MRI of spine and pelvis should be considered in:

• All patients with suspected solitary plasmacytoma (mandatory) 1
• Smoldering (asymptomatic) myeloma - detects occult lesions and predicts progression 1

Special Circumstances

When Amyloidosis is Suspected

If clinical features suggest amyloid light chain (AL) amyloidosis in a patient with paraproteinemia:

• Renal biopsy with appropriate staining is necessary 1
• Abnormal free light chains with sensory/autonomic neuropathy warrant amyloidosis evaluation 2

Hyperviscosity Assessment

Routine testing for hyperviscosity is NOT recommended 1:

• Laboratory hyperviscosity values correlate poorly with clinical manifestations
• Funduscopic examination is more clinically useful 1
• Hyperviscosity in IgG myeloma is rare unless IgG subclass 3 1

IgM Paraproteinemia Considerations

For IgM paraproteins (Waldenström macroglobulinemia):

• M-spike quantitation by SPEP can be unreliable due to IgM migration patterns and complex formation 3
• IgM heavy chain nephelometry should be considered as alternative quantitation method 3
• MYD88L265P mutation testing is valuable (present in >90% of cases) 4

Common Pitfalls to Avoid

1. Do not rely on random urine samples - 24-hour collection is mandatory for accurate assessment 1
2. Do not skip immunofixation even when SPEP appears normal - up to 24% of patients with isolated hypogammaglobulinemia harbor paraproteins 5
3. Do not use SPEP alone - nephelometric quantitation is complementary and essential 1
4. Do not omit serum free light chains - critical for detecting nonsecretory disease 1
5. Do not order C-reactive protein for myeloma risk assessment - only useful if infection suspected 1

This comprehensive workup allows accurate diagnosis, risk stratification, and appropriate treatment planning for patients with paraproteinemia, directly impacting morbidity and mortality through early detection of high-risk features and end-organ damage.